Virginia Barras Sánchez/ LinkedIn
Jul 17, 2026, 18:06
Virginia Barras Sánchez: United by a Commitment to Hemophilia at ISTH 2026
Virginia Barras Sánchez, Medical Manager Hematology at Roche, shared a post on LinkedIn:
“What a week at ISTH 2026 in Paris!
A week of science, collaboration and meaningful conversations.
From Global meetings to connecting with colleagues from across the world and engaging with the hemophilia community at ISTH 2026, this week reinforced what makes me most proud to work at Roche: our long-standing commitment to people living with hemophilia and our shared ambition to keep advancing care through the science, partnership and innovation that make a difference.
Grateful to be part of such an inspiring team!
Here for generations. Here for life.”
Stay updated with Hemostasis Today.
-
Sep 3, 2026, 04:09Pedro Perez: Are We Entering a New Era in the Treatment of Intermediate-High-Risk PE?
-
Sep 3, 2026, 04:01Marianne Yee: Supporting Families and Transformative Therapies in Sickle Cell Disease
-
Sep 3, 2026, 03:51Strengthening Bleeding Disorders Care in New Zealand – WFH
-
Sep 3, 2026, 03:42Nathan Connell: FDA Approves Rusfertide for Polycythemia Vera
-
Sep 3, 2026, 03:28Katrina Snow: Learning More About Sickle Cell Disease This September
-
Sep 3, 2026, 01:19Himanshu Aggarwal: 1 mg/kg/d Thalidomide Non-Inferior to Standard Dose in Transfusion-Dependent Thalassemia
-
Sep 3, 2026, 01:03SHOT Urges Safe Component Matching While NHSBT Appeals for Black Donors
-
Sep 3, 2026, 00:52David Wallace: FDA Approves MIMRYLO to Target Iron Regulation and Reduce Phlebotomy Burden
-
Sep 3, 2026, 00:44Same goal, Different molecular strategy – Which FVIIIa Mimetic Gets There How? – RPTH Journal